Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Protocol of the randomized controlled trial of electronic Patient-Reported Outcome Monitoring with Integrated hospital–community pharmaciSt Engagement for diverse outpatient anticancer chemotherapy: the PRO-MISE trial
Itsuki Osawa; Tohru Takebe; Shuhei Saito; Michiko Yamazaki; Tomoya Saika; Hideyuki Ohzawa; Shunsuke Yui; Hiroki Yamaguchi; Yasushi Imai; Takuhiro Yamaguchi; Shunya IkedaShow moreShow less
1. Okinaka Memorial Institute for Medical Research, Tokyo, Japan; 2. KAKEHASHI Inc., Tokyo, Japan; 3. Department of Social Medical Sciences, Graduate School of Medicine, International University of Health and Welfare, Tokyo, Japan; 4. Graduate School of Medical and Pharmaceutical Sciences, Chiba University, Chiba, Japan; 5. Department of Clinical Oncology, Jichi Medical University, Tochigi, Japan; 6. Department of Hematology, Nippon Medical School, Tokyo, Japan; 7. Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi, Japan; 8. Division of Biostatistics, Tohoku University Graduate School of Medicine, Miyagi, JapanShow moreShow less
Combined assessment of skeletal muscle mass and quality in allogeneic hematopoietic stem cell transplantation: a longitudinal study of physical function and complications
Ryota Hamada; Masanobu Murao; Junsuke Miyasaka; Michiko Matsushita; Ayumi Otagaki; Tsugumi Asano; Junya Kanda; Yasuyuki Arai; Akifumi Takaori-Kondo; Ryosuke Ikeguchi; Akira TamakiShow moreShow less
1. Rehabilitation Unit, Kyoto University Hospital, Kyoto, Japan; 2. Graduate School of Rehabilitation Science, Hyogo Medical University, Kobe, Japan; 3. Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 4. Department of Cytotherapy, Kyoto University Hospital, Kyoto, JapanShow moreShow less
Real-world surgical outcomes and prognostic factors in stage III–IVA laryngeal squamous cell carcinoma: a multicenter, retrospective, cohort study in northern Japan
Akira Ohkoshi; Katsunori Katagiri; Satoshi Kano; Kazutake Yagi; Hiroshi Idogawa; Satoshi Toyoma; Iori Kusaka; Takashi Kasai; Yukiko Saito; Kizuku Owada; Hisataka Ominato; Haruka Kaya; Eiichi Ishida; Kazuya Kurakami; Atsushi Yoshimura; Kenta Taguchi; Takuya Yoshida; Ryo Ishii; Kenjiro Higashi; Yukio KatoriShow moreShow less
1. Department of Otorhinolaryngology, Head and Neck Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan; 2. Department of Otolaryngology—Head and Neck Surgery, Iwate Medical University School of Medicine, Iwate Medical University, Morioka, Japan; 3. Department of Otolaryngology—Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan; 4. Department of Head and Neck Surgery, Miyagi Cancer Center, Natori, Japan; 5. Department of Otorhinolaryngology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan; 6. Department of Otolaryngology, Fukushima Medical University, Fukushima, Japan; 7. Department of Otolaryngology—Head and Neck Surgery, Sapporo Medical University, Sapporo, Japan; 8. Department of Otolaryngology—Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan; 9. Department of Otorhinolaryngology and Head and Neck Surgery, Akita University Graduate School of Medicine, Akita, Japan; 10. Department of Otorhinolaryngology—Head and Neck Surgery, National Sendai Medical Center, Sendai, Japan; 11. Department of Otolaryngology Head and Neck Surgery, Faculty of Medicine, Yamagata University, Yamagata, Japan; 12. Department of Otolaryngology, Head and Neck Surgery, Hokkaido Cancer Center, Sapporo, Japan; 13. Department of Otorhinolaryngology, Tohoku Medical and Pharmaceutical University, Sendai, JapanShow moreShow less
Patient-reported outcome sub-analysis of a phase 2 trial of bladder preservation therapy with atezolizumab and radiation therapy (BPT-ART) for invasive bladder cancer
Bryan J. Mathis; Yoshiyuki Nagumo; Tomokazu Kimura; Hitoshi Ishikawa; Yuta Sekino; Kazushi Maruo; Yukio Kageyama; Hiroki Ushijima; Jun Kamei; Hideomi Yamashita; Haruhito Azuma; Keiji Nihei; Taku Naiki; Natsuo Tomita; Yasuyuki Kobayashi; Kotaro Yoshio; Takashi Matsumoto; Tadamasa Yoshitake; Takahiro Osawa; Kentaro Nishioka; Yuki Kita; Takashi Mizowaki; Toyonori Tsuzuki; Koichi Hashimoto; Hiroyuki NishiyamaShow moreShow less
1. Department of Cardiovascular Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan; 2. Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan; 3. Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan; 4. Department of Radiation Oncology, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; 5. Department of Radiation Oncology and Proton Medical Research Center, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan; 6. Tsukuba Clinical Research & Development Organization, University of Tsukuba, Tsukuba, Japan; 7. Department of Urology, Saitama Cancer Center, Ina, Japan; 8. Department of Radiation Oncology, Saitama Cancer Center, Ina, Japan; 9. Department of Urology, The University of Tokyo, Bunkyo-ku, Japan; 10. Department of Radiation Oncology, The University of Tokyo, Bunkyo-ku, Japan; 11. Department of Urology, Osaka Medical and Pharmaceutical University Hospital, Takatsuki, Japan; 12. Department of Radiation Oncology, Osaka Medical and Pharmaceutical University, Osaka, Japan; 13. Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan; 14. Department of Radiology, Graduate School of Medical Sciences, Nagoya City University, Aichi, Japan; 15. Department of Urology, Okayama University Graduate School of Medicine, Okayama, Japan; 16. Department of Proton Beam Therapy, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan; 17. Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; 18. Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; 19. Department of Urology, Hokkaido University, Sapporo, Japan; 20. Department of Radiation Medical Science and Engineering, Faculty of Medicine, Hokkaido University, Hokkaido, Japan; 21. Department of Urology, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto, Japan; 22. Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 23. Department of Surgical Pathology Department, Aichi Medical University, Nagakute, Japan; 24. Center for Cyber Medicine Research, University of Tsukuba, Tsukuba, JapanShow moreShow less
Clinical benefit and economic value of fosnetupitant versus aprepitant in carboplatin-Based chemotherapy: a real-world study
Hiroshi Inano; Yoshihito Morimoto; Atsushi Kawamura; Taichi Ikegami; Tomoki Niizuma; Kanata Kitagawa; Rie Usami; Kozue Nakagomi; Aiko Shono; Kazuhiro Watanabe; Katsuya OtoriShow moreShow less
1. Department of Pharmacy, Kitasato University Hospital, Sagamihara, Japan; 2. Education and Research Center for Clinical Pharmacy, Showa Pharmaceutical University, Machida, Tokyo, Japan; 3. Laboratory of Public Health, Showa Pharmaceutical University, Machida, Tokyo, Japan; 4. Laboratory of Pharmacy Practice and Science I, Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University, Sagamihara, JapanShow moreShow less
Preoperative predictors for the extent of facial nerve sacrifice in parotid gland cancer: an ordinal logistic regression and nomogram analysis
Keishi Fujiwara; Satoshi Kano; Nayuta Tsushima; Hiroshi Idogawa; Hayato Imanari; Masaki Kakumu; Mai Sakai; Akihiro HommaShow moreShow less
1. Department of Otolaryngology-Head & Neck Surgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, JapanShow moreShow less
FAQ
How long does International Journal of Clinical Oncology take to review a manuscript?
As of 2026-11-19, CrushSCI has 20 complete review records for International Journal of Clinical Oncology. The fastest paper went from submission to acceptance in 30 days (AI-integrated multi-omics platform to revolutionize anti-metastatic therapy development through circulating tumor cell profiling: SCRUM-MONSTAR-CTC, received 2026-06-14, accepted 2026-07-14); the slowest took 248 days. The average is 99.0 days and the median is 92.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
